StemCells Inc. (Nasdaq: STEM) terminated a mid-stage clinical trial and will wind down the company. The stock price plummeted $2.46 to close at $0.57.
StemCells will shut down
May 31, 2016 at 16:48 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|